跳至主要内容
临床试验/CTRI/2015/01/005356
CTRI/2015/01/005356已完成Phase 3 4

CLINICAL STUDY OF PANCHAPRASRUTIKA BASTI IN SARVANGAGATA KUPITA VATA LAKSHANAS

Dr Ankita Kukreti1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2013年9月16日最近更新:

试验速览

阶段
Phase 3 4
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
improvement in subjective and objective

研究概览

简要总结

Ayurveda considers  aggravated Vata as the main contributory factor for many disorders. Sarvangagata kupita Vata is one such disorder in which there is Gatrasphurana, Bhanjana, Sarva Sandhigata Sphutita Vedana, Shula, Shotha, Kampan, Stambhan, Swapa. Basti is considered best to treat all Vata Vyadhis.Panchaprasrutika Basti (480 ml) having Madhu (Honey-96 ml),Oil (tail-96ml), cow Ghee- 96ml & Cow milk- 192ml as main ingredients is given 9 days daily in the morning at 9:30- 11 am per rectal route on empty stomach. Majority of Ingredient are having Madhur Rasa, Madhur Vipaka which provides Brumhana of Asthi Majja Dhatus and Snigdha Guna which helps in Vatahara. Panchaprasrutika Basti having Vataghana & Brumhana effect is beneficial in Sarvangagata kupita Vata. Assessment will be done on 1st and 9th day and on follow up  27th and 36th from day of starting treatment. Observations will be recorded and results will be drawn after statistical analysis and final conclusion will be made.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • 1.Patients with Lakshanas of Sarvangagata kupita Vata like Gatrasphurana, Bhanjana, Sarva Sandhi Sphutita Vedana , Stambhana, Aakshepana, Swapa, Sandhyakunjana, Kampana, Shula, Shotha.
  • 2.Patients will be selected in the age group of 18 to 70 years.
  • 3.Patient indicated for Basti Karma.
  • 4.Patient willing to take Basti.
  • 5.Patient of both sexes will be taken.

排除标准

  • Patients with intestinal TB, malignancy and other infective disorders.
  • Basti Anarha patients.
  • Patients undergoing other modalities of treatment for Sarvangagata kupita Vata will be excluded.

结局指标

主要结局

improvement in subjective and objective

时间窗: 36

parameter

时间窗: 36

次要结局

  • To find the efficacy(treatment in Sarvangagata Kupita Vata)

研究者

发起方
Dr Ankita Kukreti
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验